Evaheart Medical USA

Evaheart USA is a medical technology startup that specializes in the development and distribution of advanced heart assist devices. Their flagship product, the EVA2, is a Left Ventricular Assist Device (LVAD) that employs a unique centrifugal pump design to support blood circulation. This device is particularly beneficial for patients with severe heart conditions, as it aids in maintaining the natural pulsatility of the heart.

The EVA2's innovative design includes a hydraulically levitated impeller, which is a type of rotor used to increase the pressure and flow of blood. This impeller is lubricated with sterile water to minimize the risk of clot formation, a common complication in heart assist devices. The device also features a novel double cuff tipless inflow cannula, a tube inserted into the heart to help pump blood, designed to improve anatomical fitting and potentially reduce post-LVAD stroke.

Evaheart USA operates in the medical device market, specifically targeting the cardiovascular sector. Their business model revolves around the development, production, and sale of their heart assist devices to healthcare providers. The company generates revenue through the sale of these devices, which are then used by medical professionals to treat patients with severe heart conditions.

In summary, Evaheart USA is a promising startup in the medical technology sector, offering innovative solutions for severe heart conditions. Their unique product design and focus on patient safety position them well in the growing cardiovascular device market.

Keywords: Medical Technology, Heart Assist Devices, LVAD, Centrifugal Pump, Hydraulic Levitation, Impeller, Blood Circulation, Double Cuff Tipless Inflow Cannula, Cardiovascular Sector, Patient Safety.